C91.02
C91.02 — Acute lymphoblastic leukemia, in relapse
Billable / specific codeICD-10-CM
C91.02 is a billable, specific ICD-10-CM code for acute lymphoblastic leukemia, in relapse. It is valid for submission on a claim.
Risk adjustment
C91.02 risk-adjusts. Under the CMS-HCC V28 model it maps to these categories:
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C91.02 is named in 80 Medicare coverage policies — 80 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C91.0. If C91.02 is not quite right, the correct code is usually one of these.
Questions about C91.02
- Is C91.02 a billable ICD-10-CM code?
- Yes. C91.02 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C91.02 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).